The ASX materials sector has surged to record highs on booming copper and gold prices. Are mining stocks overheated or still offering value?
Gold prices are at record highs as Titan Minerals (ASX:TTM) delivers standout drill results in Ecuador and attracts strategic investor interest.
The global wound care market is expanding as diabetes and ageing trends lift demand for advanced treatments. See where PolyNovo (ASX: PNV) fits, what’s driving growth, and the key risks investors should weigh.
Pentagon funding puts IperionX (ASX:IPX) in the spotlight. See what the US$146m contract capacity means for US titanium reshoring, growth targets, and key risks for investors.
BlueScope (ASX: BSL) has rejected a fourth takeover bid, then announced a A$438m special dividend. Is the board right to hold out, or is the market pricing in a higher offer? Read the key signals.
Rhythm Biosciences (ASX: RHY) has upgraded its geneType CRC risk test while ColoSTAT commercialisation ramps up. Here’s what the update means for revenue potential, key catalysts (NATA and NHS), and the main risks investors should watch.
If you have any questions or feedback about our service, please feel free to contact us.